{"count": 3, "results": [{"_id": "17159370", "pmid": 17159370, "title": "Homozygous familial hypercholesterolemia with generalized arterial disease.", "journal": "Med Princ Pract", "authors": ["Selvan JP", "Uthaman B", "Abushaban L", "Jebaraj R"], "date": "2007-01-01T00:00:00Z", "doi": "10.1159/000096146", "meta_date_publication": "2007", "meta_volume": "16", "meta_issue": "1", "meta_pages": "75-8", "score": 50064.82, "text_hl": "@DISEASE_Homozygous_Familial_Hypercholesterolemia @DISEASE_MESH:D000090542 @@@Homozygous familial hypercholesterolemia@@@ with generalized @<m>DISEASE_Cerebral_Arterial_Diseases</m> @DISEASE_MESH:D002539 @@@arterial disease@@@.", "citations": {"NLM": "Selvan JP, Uthaman B, Abushaban L, Jebaraj R. Homozygous familial hypercholesterolemia with generalized arterial disease. Med Princ Pract. 2007;16(1):75-8. PMID: 17159370", "BibTeX": "@article{17159370, title={Homozygous familial hypercholesterolemia with generalized arterial disease.}, author={Selvan JP and Uthaman B and Abushaban L and Jebaraj R}, journal={Med Princ Pract}, volume={16}, number={1}, pages={75-8}}"}}, {"_id": "14500049", "pmid": 14500049, "title": "A matter of life and death? The Heart Protection Study and protection of clinical trial participants.", "journal": "Control Clin Trials", "authors": ["Migrino RQ", "Topol EJ", "Heart Protection Study"], "date": "2003-10-01T00:00:00Z", "doi": "10.1016/s0197-2456(03)00091-6", "meta_date_publication": "2003 Oct", "meta_volume": "24", "meta_issue": "5", "meta_pages": "501-5", "score": 50048.168, "text_hl": "The Heart Protection Study is one such trial, and it showed significant mortality reduction following 5 years of treatment with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ compared with placebo in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Cerebral_Arterial_Diseases</m> @DISEASE_MESH:D002539 @@@arterial disease@@@ and/or @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@. ", "citations": {"NLM": "Migrino RQ, Topol EJ, Heart Protection Study. A matter of life and death? The Heart Protection Study and protection of clinical trial participants. Control Clin Trials. 2003 Oct;24(5):501-5. PMID: 14500049", "BibTeX": "@article{14500049, title={A matter of life and death? The Heart Protection Study and protection of clinical trial participants.}, author={Migrino RQ and Topol EJ and Heart Protection Study}, journal={Control Clin Trials}, volume={24}, number={5}, pages={501-5}}"}}, {"_id": "12114036", "pmid": 12114036, "title": "MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.", "journal": "Lancet", "authors": ["Heart Protection Study Collaborative Group"], "date": "2002-07-06T00:00:00Z", "doi": "10.1016/S0140-6736(02)09327-3", "meta_date_publication": "2002 Jul 6", "meta_volume": "360", "meta_issue": "9326", "meta_pages": "7-22", "score": 50043.11, "text_hl": "METHODS: 20,536 UK adults (aged 40-80 years) with @DISEASE_Coronary_Disease @DISEASE_MESH:D003327 @@@coronary disease@@@, other @DISEASE_Arterial_Occlusive_Diseases @DISEASE_MESH:D001157 @@@occlusive@@@ @<m>DISEASE_Cerebral_Arterial_Diseases</m> @DISEASE_MESH:D002539 @@@arterial disease@@@, or @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ were randomly allocated to receive 40 mg @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ daily (average compliance: 85%) or matching placebo (average non-study statin use: 17%). ", "citations": {"NLM": "Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002 Jul 6;360(9326):7-22. PMID: 12114036", "BibTeX": "@article{12114036, title={MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.}, author={Heart Protection Study Collaborative Group}, journal={Lancet}, volume={360}, number={9326}, pages={7-22}}"}}]}